Rafarma Pharmaceuticals, Inc. (RAFA)

OTCMKTS · Delayed Price · Currency is USD
0.0670
-0.0050 (-6.94%)
Mar 13, 2026, 10:05 AM EST
Market Cap7.02M -24.0%
Revenue (ttm)133.33K
Net Income-117.22K
EPS-0.01
Shares Out87.77M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume10,000
Average Volume34,388
Open0.0670
Previous Close0.0720
Day's Range0.0670 - 0.0670
52-Week Range0.0036 - 0.1779
Beta0.54
RSI52.20
Earnings Daten/a

About Rafarma Pharmaceuticals

Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. It offers cephalosporin-based products, antibiotics of non-ß structure, and anti-cancer drugs in the form of injections, ampulla packaged products, child suspensions, tablets, and capsules. The company also provides drugs for accidental wounds, inflammatory eye diseases, and immunological disorders. The company has a collaboration agreement with PlantEXT Ltd. to research and manufacture t... [Read more]

Sector Healthcare
Country United States
Stock Exchange OTCMKTS
Ticker Symbol RAFA
Full Company Profile

Financial Performance

Financial Statements